Exogenous luminal nitric oxide exposure accelerates columnar transformation of rat esophagus.
Exposure of the esophageal mucosa to refluxed gastroduodenal contents is recognized to be an important risk factor for Barrett's esophagus (BE). At the human gastroesophageal junction, nitric oxide is generated luminally through the enterosalivary recirculation of dietary nitrate, and in cases with gastroesophageal reflux, the site of luminal nitric oxide generation could shift to the distal esophagus. The aim of this study is to investigate whether exogenous luminal nitric oxide could promote the development of BE in rats. Sodium nitrite plus ascorbic acid were administered to a rat surgical model of BE, in which the gastroduodenal contents were refluxed into the esophagus to generate exogenous luminal nitric oxide in the esophagus by the acid-catalyzed chemical reaction between the 2 reagents. The emergence of BE was evaluated histologically in the early phase (several weeks) after the surgery with or without exogenous nitric oxide administration. To elucidate the histogenesis of BE, CDX2, MUC2 and MUC6 expressions were investigated immunohistochemically. Coadministration of sodium nitrite plus ascorbic acid significantly accelerated the timing of emergence and increased the area of BE compared with controls. Administration of either reagent alone did not show any promotive effects on BE formation. Immunohistochemically, the columnar epithelium thus induced was similar to the specialized intestinal metaplasia in human BE. The results of this animal model study suggest that exogenous luminal nitric oxide could be involved in the pathogenesis of the columnar transformation of the esophagus. Further studies in human are warranted.
Endo
Hiroyuki
H
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Iijima
Katsunori
K
Asanuma
Kiyotaka
K
Ara
Nobuyuki
N
Ito
Hirotaka
H
Asano
Naoki
N
Uno
Kaname
K
Koike
Tomoyuki
T
Imatani
Akira
A
Shimosegawa
Tooru
T
D000818:Animals; D001205:Ascorbic Acid / Q000737:chemistry; D001471:Barrett Esophagus / Q000139:chemically induced* / Q000473:pathology; D004195:Disease Models, Animal; D004941:Esophagitis / Q000139:chemically induced / Q000473:pathology; D005764:Gastroesophageal Reflux / Q000378:metabolism*; D009569:Nitric Oxide / Q000494:pharmacology*; D011897:Random Allocation; D051381:Rats; D012977:Sodium Nitrite / Q000737:chemistry
D009569:Nitric Oxide; D012977:Sodium Nitrite; D001205:Ascorbic Acid